Support@cbd-international.clinic
10+
Years of Care
12k+
Clients Helped
98%
Satisfaction
4
Product Lines
About the Clinic
A decade of dedicated, evidence-based alternative care.
Since 2016, CBD International World Clinic has been enhancing client care through evidence-based alternatives focused on cannabinoid therapeutics. We specialize in personalized plans for individuals seeking relief from chronic pain, mental health concerns, and treatment-resistant conditions.
Every formulation is laboratory-tested, every protocol is clinician-reviewed, and every client receives a plan built around their unique physiology and goals.
Our Treatments
Explore Our Therapeutic
Categories
Carefully formulated product lines designed for specific therapeutic outcomes — each
backed by a decade of clinical experience.
Featured Products
Best Sellers
Most-loved formulations from our clients — clinician-recommended and rigorously tested.
How It Works
Personalized Care in Four
Simple Steps
From your first assessment to ongoing support — we walk with you every step of the way.
1
Complete Assessment
Fill out our confidential health assessment form so we understand your needs.
2
Clinician Review
A qualified clinician reviews your case and designs a personalized protocol.
3
Discreet Delivery
Your prescribed formulations arrive in unmarked, secure packaging.
4
Ongoing Support
Continuous follow-ups and adjustments to help you reach your goals.
Begin Your Journey
Ready for a personalized
treatment plan?
Take our confidential 5-minute assessment and one of our clinicians will craft a recommendation tailored to you.
Shared Thoughts
Shared Thoughts & Testimonials
Real words from real clients of CBD International World Clinic.
Insights & Education
From Our Journal
Evidence-based articles on cannabinoid and psilocybin therapeutics, written by our clinical team.
Adjurex™ Pretreatment for Ivermectin
Advanced Cannabinoid-Mediated Pharmacokinetic Pretreatment for Ivermectin Adjurex™™ is a precision-formulated THC-HS (Non-Euphoric) pharmacokinetic pretreatment designed to be administered rectally 6 hours before a separately
ENDURA STUDY: Rectally Administered Endura Suppositories for the Relief of Cancer-Associated Symptoms
Lead researcher: Dr. Amara Venn, Dr. Michelle Sweeney Trial designation: ENDURA-01Z Study type: Prospective, open-label, single-arm pilot study Participants: 30
Dr. Michelle Sweeney Nominated as Executive Clinician at CBD International World Clinic
May 17, 2026 CBD International World Clinic is pleased to announce the nomination of Dr. Michelle Sweeney to the position